• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Recent Advances in the Study of 1219803-10-7 and 2-(N-Benzyl-N-Methyl)aMinoethanol-1,1,2,2-d4

The chemical compound 1219803-10-7 and its deuterated analog, 2-(N-Benzyl-N-Methyl)aMinoethanol-1,1,2,2-d4, have recently garnered significant attention in the field of chemical biology and pharmaceutical research. These compounds are of particular interest due to their potential applications in drug discovery, metabolic studies, and as intermediates in the synthesis of more complex molecules. This research brief aims to provide an overview of the latest findings related to these compounds, highlighting their synthesis, characterization, and biological relevance.

Recent studies have focused on the synthesis and optimization of 2-(N-Benzyl-N-Methyl)aMinoethanol-1,1,2,2-d4, a deuterated version of the parent compound. Deuterated compounds are increasingly used in pharmaceutical research due to their enhanced metabolic stability and ability to serve as internal standards in mass spectrometry. The synthesis of this deuterated analog involves the incorporation of four deuterium atoms at specific positions, which has been achieved through advanced catalytic methods and isotopic labeling techniques. Researchers have reported high yields and purity, making this compound a valuable tool for pharmacokinetic and pharmacodynamic studies.

In addition to its synthetic utility, 1219803-10-7 has been investigated for its potential biological activities. Preliminary in vitro studies suggest that this compound may exhibit modulatory effects on certain enzymatic pathways, although the exact mechanisms remain under investigation. The deuterated analog, 2-(N-Benzyl-N-Methyl)aMinoethanol-1,1,2,2-d4, has been used in tracer studies to elucidate metabolic pathways and identify potential drug-drug interactions. These findings underscore the importance of isotopic labeling in advancing our understanding of drug metabolism and toxicity.

One of the key challenges in working with these compounds is their stability under various physiological conditions. Recent research has addressed this issue by exploring formulation strategies that enhance the stability and bioavailability of 1219803-10-7 and its deuterated counterpart. For instance, encapsulation in lipid-based nanoparticles has shown promise in improving the delivery and sustained release of these compounds, thereby enhancing their therapeutic potential.

Looking ahead, the continued exploration of 1219803-10-7 and 2-(N-Benzyl-N-Methyl)aMinoethanol-1,1,2,2-d4 is expected to yield further insights into their applications in drug development and metabolic research. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to fully harness the potential of these compounds. Future studies may also focus on expanding the library of deuterated analogs to explore structure-activity relationships and optimize their pharmacological properties.

In conclusion, the recent advancements in the study of 1219803-10-7 and 2-(N-Benzyl-N-Methyl)aMinoethanol-1,1,2,2-d4 highlight their growing importance in chemical biology and pharmaceutical sciences. These compounds offer unique opportunities for drug discovery and metabolic research, and ongoing investigations are likely to uncover new applications and therapeutic avenues. As the field progresses, it will be crucial to maintain a focus on innovation and interdisciplinary collaboration to maximize the impact of these findings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)